AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2013
Jan 29, 2013
34117_dirs_2013-01-29_47915bd1-3097-497f-a70d-8a65c2b40226.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2013-01-25
Reporting Person: JOHNSON BRUCE F (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-25 | 8% Convertible Debentures Due 2015 | $0.15 | P | Acquired | 2015-01-25 | Common Stock (666700) | Direct | |
| 2013-01-25 | Common Stock Purchase Warrant | $0.3 | P | 333300 | Acquired | 2016-01-25 | Common Stock (333300) | Direct |
Footnotes
F1: On January 25, 2013, the reporting person purchased $100,000 principal amount of Convertible Debentures and warrants to purchase 333,300 shares of Common Stock from CopyTele, Inc. in a private placement for an aggregate purchase price of $100,000
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6